FFA
LEGN icon

Farther Finance Advisors’s Legend Biotech LEGN Stock Holding History

Farther Finance Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2K Sell
798
-334
-30% -$9.01K ﹤0.01% 3868
2026
Q1 		$21.6K Buy
1,132
+191
+20% +$3.64K ﹤0.01% 3605
2025
Q4 		$20.5K Buy
941
+906
+2,589% +$26K ﹤0.01% 3426
2025
Q3 		$1.14K Sell
35
-34
-49% -$1.25K ﹤0.01% 4328
2025
Q2 		$2.45K Sell
69
-397
-85% -$12.9K ﹤0.01% 3635
2025
Q1 		$14.7K Buy
466
+444
+2,018% +$15.9K ﹤0.01% 2544
2024
Q4 		$716 Sell
22
-53
-71% -$2.19K ﹤0.01% 3353
2024
Q3 		$3.65K Buy
75
+18
+32% +$959 ﹤0.01% 2773
2024
Q2 		$2.62K Buy
57
+6
+12% +$277 ﹤0.01% 2682
2024
Q1 		$2.92K Buy
+51
New +$3.08K ﹤0.01% 2331

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FHC
First Horizon Corporation Memphis, Tennessee $2.6B AUM 23.72% 1-Year Est. Return

Farther Finance Advisors's LEGN Position: Q2 2026 in Review

Farther Finance Advisors reduced its Legend Biotech (LEGN) stake by 30% in Q2 2026, selling an estimated $9.01K and leaving 798 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

Farther Finance Advisors first reported a position in LEGN in Q1 2024 and has held it in 10 quarters since. 18 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Farther Finance Advisors held 798 shares of Legend Biotech worth $23.2K as of Q2 2026.
  • Farther Finance Advisors sold 334 Legend Biotech shares in Q2 2026, an estimated $9.01K.
  • Legend Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3868 holding.
  • Farther Finance Advisors first reported a position in Legend Biotech in Q1 2024 and has held it in 10 quarters since.
  • 18 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.